Decentralised Clinical Trials market is projected to grow
Visiongain has published a new report entitled Decentralised Clinical Trials 2023-2033. Forecasts by Indication (Oncology, Cardiovascular,...
Source: globenewswire.com
Page 31 - Study Design News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Study Design. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Study Design Today - Breaking & Trending Today
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at Upcoming Scientific Meetings
Results from the EXPEDITE study of Remodulin® induction prior to Orenitram® therapy to be presented at ATS Baseline patient data from the TETON studies of Tyvaso® Inhalation Solution in... | April 18, 2023
Source: marketscreener.com
Contract Research Organization (CRO) Market Size to Surpass USD 115.19 Billion by 2030 at 12.01% CAGR | MRFR |
Contract Research Organization (CRO) Market Research Report: Information By Type (Drug Discovery, Clinical Development), By Clinical trial (Preclinical
Source: medgadget.com
Investegate |atai Life Sciences Announcements | atai Life Sciences: atai Life Sciences Announces Results from Phase 2a Trial of PCN-101 (R-ketamine) for Treatment-Resistant Depression
Investegate announcements from atai Life Sciences, atai Life Sciences Announces Results from Phase 2a Trial of PCN-101 (R-ketamine) for Treatment-Resistant Depression
Source: investegate.co.uk
atai Life Sciences Announces Results from Phase 2a Trial of PCN-101 (R-ketamine) for Treatment-Resistant Depression
NEW YORK and BERLIN, Jan. 06, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) ("atai" or "the Company"), a clinical-stage biopharmaceutical company focused on mental health, announced that,
Source: finanznachrichten.de